Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Naloxone in Healthy Volunteers Exposed to Remifentanil
NCT02405988Phase 1Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Apr 2015
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of naloxone in opioid overdose, sponsored by Norwegian University of Science and Technology. Primary endpoint: Serum-effect-site equilibration rate constant at 120 minutes. Started Apr 2015; status: completed.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT02405988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02405988.